{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Recurrent PTPN14 Mutations in Trichilemmoma: Evidence for Distinct Pathways of Molecular Pathogenesis

Activity Steps


Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe the histopathologic features of trichilemmoma.
  2. Compare and contrast pathways of the molecular pathogenesis of trichilemmoma.
  3. Analyze the emerging role of PTPN14 as a tumor suppressor gene.
Price: $15.00


  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: AJD0822
Published: August 2022
Expires: 7/31/2024
Required Passing Score: 4/5 (80%)
Authors: Eleanor Russell-Goldman, MD, PhD, Fei Dong, MD, and John Hanna, MD, PhD
Categories: Dermatology , Pathology
Topics: Trichilemmoma